跳至主要内容
临床试验/NL-OMON50560
NL-OMON50560已完成不适用

Reappraisal of Atrial Fibrillation: Interaction between HyperCoagulability, Electrical Remodeling, and Vascular Destabilisation in the Progression of AF - An observational exploratory study on pathophysiological mechanisms of AF progression AND on the role of LinQ/ CareLink guided patient tailored therapy in patients with AF (RACE V) - RACE V

Academisch Medisch Centrum0 个研究点目标入组 750 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
750

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • Age > 18 years;
  • Total history <10 years of paroxysmal, self-terminating AF;
  • At least one documented episode of AF and 2 symptomatic episodes or two
  • documented episodes, documented as:
  • o AF on ECG, Holter-recording, loop recorder, event recorder or MyDiagnostic;
  • o Subclinical AF (SCAF) detected in a Medtronic pacemaker (atrial read > 190
  • bpm lasting > 6 minutes).
  • Able and willing to sign informed consent for the registry;
  • Able and willing to undergo implantation of ILR (in patients without a CIED);
  • CHA2DS2-VASc score <=5
  • No other indication for oral anticoagulation (e.g. mechanical valve
  • prosthesis)

排除标准

  • Non-self-terminating, persistent AF;
  • Only AF due to a trigger (i.e. postoperative, due to infection);
  • Congenital heart disease;
  • Refusing to temporarily stop (N)OAC for coagulation phenotyping (in patients
  • already on (N)OAC before inclusion in this study), with the exception for
  • patients with a history of ischemic stroke/ transient ischemic attack;
  • Prior pulmonary vein isolation (PVI) or on waiting list for PVI or expected
  • to be placed on waiting list within one year;
  • Expected to start with, or currently using amiodarone;
  • Pregnancy;
  • ICD, CRT or pacemaker that is not a Medtronic pacemaker;
  • Life expectancy of less than 2.5 years.;
  • Ventricular pacing >50% In patients with a Medtronic pacemaker.

研究者

相似试验